PROTIA Inc

PROTIA Inc

PROTIA Inc. is dedicated to advancing human health and well-being by discovering novel protein targets for disease prediction, early diagnosis, and the development of innovative therapeutics.
We develop cutting-edge in vitro diagnostic (IVD) technologies tailored to the specific needs of our customers and provide products with distinctive competitive advantages. Our product portfolio includes diagnostic kits for human and animal allergies, autoimmune diseases, immune monitoring, next-generation pregnancy testing, and antimicrobial susceptibility testing.
PROTIA Allergy-Q is a multiplex diagnostic platform capable of simultaneously analyzing over 300 allergens. PROTIA Q-AST is a quick antimicrobial susceptibility test utilizing a capacitive sensor, delivering results within hours. In addition, PROTIA offers point-of-care testing solutions that enable immune status assessment using saliva or whole blood.

Allergy Testing, Animal Diagnostics, Autoimmune Disease Testing, Multiplex Testing, Point of Care Testing, Pregnancy Testing, Rapid Tests, Immunoassay Systems, Home Care Testing, Biosensors/Electrodes

Yes

Yes

Distributor/Agent/Representative

Afghanistan, Albania, American Samoa, Andorra, Angola, Anguilla, Antarctica, Antigua and Barbuda, Argentina, Armenia, Aruba, Australia, Austria, Bahamas, Bangladesh, Barbados, Belgium, Belize, Benin, Bermuda, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Bouvet Island, Brazil, British Indian Ocean Territory, Brunei Darussalam, Bulgaria, Burkina Faso, Burundi, Cambodia, Cameroon, Canada, Cape Verde, Cayman Islands, Central African Republic, Chad, China, Christmas Island, Cocos (Keeling Islands), Colombia, Comoros, Congo, Cook Islands, Costa Rica, Cote D'Ivoire (Ivory Coast), Cuba, Cyprus, Denmark, Djibouti, East Timor, Eritrea, Estonia, Ethiopia, Falkland Islands (Malvinas), Faroe Islands, Fiji, Finland, France, France, Metropolitan, French Guiana, French Polynesia, French Southern Territories, Gabon, Gambia, Germany, Ghana, Gibraltar, Greece, Greenland, Grenada, Guadeloupe, Guam, Guatemala, Guinea, Guinea-Bissau, Guyana, Haiti, Heard and McDonald Islands, Hong Kong, Hungary, Iceland, Iran, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kenya, Kiribati, Kyrgyzstan, Laos, Latvia, Lebanon, Lesotho, Liberia, Libya, Liechtenstein, Lithuania, Luxembourg, Macau, Macedonia, Madagascar, Malawi, Mali, Malta, Marshall Islands, Martinique, Mauritania, Mayotte, Mexico, Micronesia, Moldova, Monaco, Mongolia, Morocco, Mozambique, Myanmar, Namibia, Nauru, Nepal, Netherlands, Netherlands Antilles, New Caledonia, New Zealand, Nicaragua, Niger, Nigeria, Niue, Norfolk Island, Northern Mariana Islands, Norway, Oman, Pakistan, Palau, Panama, Papua New Guinea, Paraguay, Pitcairn, Poland, Portugal, Puerto Rico, Romania, Russian Federation, Rwanda, S. Georgia and S. Sandwich Isls., Saint Kitts and Nevis, Saint Lucia, Saint Vincent and The Grenadines, Samoa, San Marino, Sao Tome and Principe, Senegal, Seychelles, Sierra Leone, Singapore, Slovak Republic, Slovenia, Solomon Islands, Somalia, South Africa, Spain, Sri Lanka, St. Helena, St. Pierre and Miquelon, Sudan, Suriname, Svalbard and Jan Mayen Islands, Swaziland, Sweden, Switzerland, Syria, Taiwan, Tajikistan, Tanzania, Thailand, Togo, Tokelau, Tonga, Trinidad and Tobago, Tunisia, Turkmenistan, Turks and Caicos Islands, Tuvalu, US Minor Outlying Islands, Uganda, Ukraine, United Kingdom, United States, Uruguay, Vanuatu, Vatican City State, Venezuela, Virgin Islands (British), Virgin Islands (US), Wallis and Futuna Islands, Western Sahara, Yemen, Yugoslavia, Zaire